For identifying the best high-growth projects within the medical-scientific ecosystem, Utopia has built a comprehensive network involving national and international stakeholders, including accelerators and incubators, leading academic institutions, centers of research excellence, and Venture Capital funds.

In project selection, UTOPIA SIS is oriented towards innovative entities that have developed potential therapies for health needs currently lacking viable alternatives.

The scientific aspect represents the focal point in the evaluation of companies.